Discontinuation report APO-NIZATIDINE

Last updated on 2017-03-13 History
Report ID 1135
Drug Identification Number 02220164
Brand name APO-NIZATIDINE
Common or Proper name NIZATIDINE
Company Name APOTEX INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) NIZATIDINE
Strength(s) 300MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 100 BTL
ATC code A02BA
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2014-04-17
Remaining supply date 2014-04-17
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2017-03-13 French Compare
v1 2017-03-13 English Compare

Showing 1 to 2 of 2